Efficacy of the MovinCog Intervention in Children

NCT ID: NCT03255499

Last Updated: 2020-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-10

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to test the efficacy of the MovinCog Intervention to enhance cognitive abilities in children 7-15 yrs. The intervention consists of two parts: a physical exercise regimen, based on high-intensity training, and a cognitive training component. The design will contrast the intervention with an active control group, matched for expectancy effects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Specifically, the investigators will compare both components together (exercise and cognitive training) against either one of the components (exercise alone, or cognitive training alone) and against an active control group. The study will include measures of scholastic aptitude, as well as of working memory and cognitive control (primary outcome measures), two cognitive abilities that are critical to daily life activities, and that respond well to training. In addition, the investigators will measure physiological responses to training, to monitor changes associated with exercise (secondary outcome measures). Finally, the investigators will relate training-specific improvements with transfer gains, to better model the interaction between training and transfer. This will provide a comprehensive understanding of the dynamics associated with the intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Learning Disorders Learning Disabilities Cognitive Change

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cognitive training physical exercise brain dynamics cognitive abilities physiological markers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise and cognitive training

This intervention includes a combination of high-intensity exercise (10min/day) and computerized cognitive training (20min/day). The software for the latter has been developed by our group, and includes 8 mini-games targeting different cognitive abilities. Both are developed for the MovinCog intervention. The intervention is personalized, based on individual performance.

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

Exercise

Cognitive

Intervention Type BEHAVIORAL

Cognitive

Exercise

High-intensity training regimen, 10min/day. Developed for the MovinCog intervention.

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

Exercise

Cognitive training

Computerized cognitive training, 20min/day. Developed for the MovinCog intervention.

Group Type EXPERIMENTAL

Cognitive

Intervention Type BEHAVIORAL

Cognitive

Games

The active control is composed of a blend of board games, computer games, and trivia quizzes. Specific content is personalized based on individual preferences, so as to reflect the flexibility of the experimental arms.

Group Type ACTIVE_COMPARATOR

Active control

Intervention Type BEHAVIORAL

Active control, including a blend of computer games, board games, quizzes, trivia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Exercise

Intervention Type BEHAVIORAL

Cognitive

Cognitive

Intervention Type BEHAVIORAL

Active control

Active control, including a blend of computer games, board games, quizzes, trivia

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 7-15

* History of seizures, brain trauma
Minimum Eligible Age

7 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Auckland, New Zealand

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David Moreau

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Moreau

Role: PRINCIPAL_INVESTIGATOR

University of Auckland, New Zealand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Auckland

Auckland, , New Zealand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

New Zealand

References

Explore related publications, articles, or registry entries linked to this study.

Moreau D, Kirk IJ, Waldie KE. High-intensity training enhances executive function in children in a randomized, placebo-controlled trial. Elife. 2017 Aug 22;6:e25062. doi: 10.7554/eLife.25062.

Reference Type DERIVED
PMID: 28825973 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MC081017

Identifier Type: -

Identifier Source: org_study_id